Jacopo Mambella
A5084805388- COVID-19 Clinical Research Studies
- COVID-19 and healthcare impacts
- Venous Thromboembolism Diagnosis and Management
- Long-Term Effects of COVID-19
- Vitamin C and Antioxidants Research
- Heart Failure Treatment and Management
- Diabetes Treatment and Management
- Dermatological and COVID-19 studies
- Celiac Disease Research and Management
- Vitamin D Research Studies
- Diabetes and associated disorders
- Nutrition and Health in Aging
- Cardiovascular Function and Risk Factors
- SARS-CoV-2 and COVID-19 Research
University of Pavia
2022
Corvid Technologies (United States)
2021
Policlinico San Matteo Fondazione
2021
Istituti di Ricovero e Cura a Carattere Scientifico
2021
Little is known regarding coronavirus disease 2019 (COVID-19) clinical spectrum in non-Asian populations. We herein describe the impact of COVID-19 on liver function 100 consecutive patients (median age 70 years, range 25-97; 79 males) who were admitted to our internal medicine unit March 2020. retrospectively assessed tests, taking into account demographic characteristics and outcome. A patient was considered as having injury when alanine aminotransferase (ALT) > 50 mU/ml, gamma-glutamyl...
SummaryBackground & aimsTo investigate the association between parameters used in nutritional screening assessment (body mass index [BMI], unintentional weight loss [WL] and reduced food intake) clinical outcomes non-critically ill, hospitalized coronavirus disease 2019 (COVID-19) patients.MethodsThis was a prospective multicenter real-life study carried out during first pandemic wave 11 Italian Hospitals. In total, 1391 patients were included. The primary end-point composite of in-hospital...
Few conflicting data are currently available on the risk of SARS-CoV-2 infection in patients with autoimmune disorders. The studies performed so far influenced, most cases, by treatment immunosuppressive drugs, making it difficult to ascertain burden autoimmunity per se. For this reason, herein we assessed susceptibility COVID-19 drug-naïve diseases, such as gastritis (AIG), celiac disease (CD), type 1 diabetes (T1D), and thyroid (AITD). Telephone interviews were conducted 400 patients-100...
Abstract Preliminary evidence supports the notion that COVID-19 patients may have an increased susceptibility to develop venous thromboembolism (VTE). However, magnitude of this association still needs be defined. Furthermore, clinical predictors thrombogenesis, and relationship with inflammatory status are currently unknown. On basis, we conducted a retrospective, observational study on 259 consecutive admitted academic tertiary referral hospital in Northern Italy between March 19th April...
Aims: primary outcomes - cardiovascular and all-cause mortality evaluation within 1 year in elderly patients enrolled with Angiotensin Receptor Inhibitor (ARNI) and/or Sodium Glucose Co-Transporter Type 2 Inhibitors (SGLT2-i) an Internal Medicine Department; recurrent hospitalization assessment for acute Heart Failure Reduced Ejection Fraction (HFrEF); length of analysis compared to not-enrolled patients. Secondary endpoints identify any parameters predicting the hospitalization; safety...